Lionhealth Società Benefit

Lionhealth Società Benefit is a health-tech startup founded in 2022, specializing in clinical nutrition. The company develops Foods for Special Medical Purposes (FSMPs), which are scientifically formulated nutritional products designed to meet the specific dietary needs of patients with conditions like malnutrition, rare diseases, cancer, and Alzheimer's. These products are intended for individuals who cannot meet their nutritional requirements through normal food consumption alone.

The company was founded by Paola (Elena) Lanati, an entrepreneur with 25 years of experience in the life sciences sector, including executive roles at major pharmaceutical companies. She is also the vice president of Italian Angels for Biotech (IAB). Lionhealth was established through the acquisition of Gemelli Health System, a 2022 spin-off from the Policlinico Gemelli in Rome. This acquisition included thirteen patented medical foods.

Lionhealth's business model is centered on a reimbursed market driven by prescriptions from medical specialists. The company combines scientific evidence with natural extracts to create antioxidant ingredient blends tailored to patient needs. Its first product, LH VIOLA, is designed for patients with protein-energy malnutrition and sarcopenia. The firm's revenue is generated through the sale of these specialized nutritional products. In June 2025, Lionhealth announced the closing of a €3 million funding round to support team growth, the launch of its first product in Italy, and the development of a second product planned for Q1 2026.

Keywords: clinical nutrition, medical foods, Foods for Special Medical Purposes, FSMPs, disease-related malnutrition, health-tech, nutritional support, life sciences, oncology nutrition, rare disease nutrition, Alzheimer's nutrition, metabolic support, diet therapy, patented formulations, Gemelli Health System, Paola Lanati, chronic inflammatory bowel disease, sarcopenia, protein-energy malnutrition, natural extracts